Article info
PDFGenotype-phenotype correlations
Original research
Lyso-Gb3 associates with adverse long-term outcome in patients with Fabry disease
- Correspondence to Dr Albina Nowak, Department of Endocrinology and Clinical Nutrition, University Hospital Zurich and University of Zurich, 8091 Zürich, Switzerland; albina.nowak{at}usz.ch
Citation
Lyso-Gb3 associates with adverse long-term outcome in patients with Fabry disease
Publication history
- Received July 13, 2020
- Revised November 6, 2020
- Accepted December 3, 2020
- First published January 25, 2021.
Online issue publication
February 18, 2022
Article Versions
- Previous version (25 January 2021).
- Previous version (18 February 2022).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.